Scarica l'app Stockscreener
1.47
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.47
Aprire:
$1.48
Volume 24 ore:
3.46M
Relative Volume:
0.45
Capitalizzazione di mercato:
$497.63M
Reddito:
$4.47M
Utile/perdita netta:
$-71.67M
Rapporto P/E:
-6.3417
EPS:
-0.2318
Flusso di cassa netto:
$-59.58M
1 W Prestazione:
-2.65%
1M Prestazione:
+23.53%
6M Prestazione:
-2.00%
1 anno Prestazione:
+27.83%
Intervallo 1D:
$1.405
$1.49
Intervallo di 1 settimana:
$1.405
$1.53
Portata 52W:
$0.931
$2.725
Ocugen Inc Stock (OCGN) Company Profile
Nome
Ocugen Inc
Settore
Industria
Telefono
484-328-4701
Indirizzo
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.47 | 497.63M | 4.47M | -71.67M | -59.58M | -0.2318 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-17 | Iniziato | Canaccord Genuity | Buy |
| 2026-03-11 | Iniziato | Oppenheimer | Outperform |
| 2024-10-15 | Iniziato | Maxim Group | Buy |
| 2023-03-01 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2022-08-23 | Iniziato | Mizuho | Buy |
| 2022-06-15 | Ripresa | ROTH Capital | Buy |
| 2022-06-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-07-26 | Iniziato | Noble Capital Markets | Outperform |
| 2021-06-11 | Downgrade | ROTH Capital | Buy → Neutral |
| 2021-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-02-09 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-02-04 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
Mostra tutto
Ocugen Inc Borsa (OCGN) Ultime notizie
Ocugen Eyes 3 Retinal Gene Therapy Filings as Late-Stage Pipeline Advances - Yahoo Finance
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances By Investing.com - Investing.com Canada
Ocugen at Piper Sandler ophthalmology day: gene therapy push advances - Investing.com
Ocugen Inc. stock falls Thursday, underperforms market - MarketWatch
Ocugen’s Triple-Threat Pipeline: A $130M Cash Injection and a Summer of Make-or-Break Data - Ad-hoc-news.de
OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data - Stocktwits
Ocugen stock stays tied to pipeline progress. Nasdaq listing keeps the US angle clear. - Ad-hoc-news.de
Ocugen Inc. stock falls Monday, underperforms market - MarketWatch
Why Did OCGN Stock Rise Today? - Stocktwits
Ocugen Inc. stock rises Thursday, outperforms market - MarketWatch
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Ocugen to Participate in Upcoming July Industry Conferences - The Manila Times
Ocugen’s July retina conference talks include OCU410 phase 2 results - Stock Titan
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Ocugen, Inc. pursues gene therapy innovation to address rare vision loss conditions - Traders Union
Ocugen Inc. stock rises Monday, outperforms market - MarketWatch
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2500 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Index - marketscreener.com
OCGN Stock Grinds Higher As Traders Track Tight Range - StocksToTrade
Ocugen’s CFO Makes a Rare Open-Market Buy as Institutional Investors Pile In Ahead of Key Gene The - AD HOC NEWS
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Value Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 2000 Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Growth Benchmark - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Ocugen, Inc.(NasdaqCM: OCGN) added to Russell 3000E Value Benchmark - marketscreener.com
Ocugen Inc. stock rises Friday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Sees Key Catalysts Ahead - StocksToTrade
Enterprise value to EBITDA forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Has Ocugen's Recent Convertible Notes Offering Stabilized Its Financial Future - Kavout | AI
Price to book forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen Inc Actuals & Estimates (NASDAQ:OCGN) - TradingView
Price to book forward of Ocugen Inc – SWB:2H51 - TradingView
Ocugen Inc (OCGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Enterprise value to revenue forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Ocugen's gene-agnostic eye therapies could reshape late-stage care - MSN
Price to earnings forward of Ocugen, Inc. – NASDAQ:OCGN - TradingView
Price to sales forward of Ocugen Inc – SWB:2H51 - TradingView
Enterprise value to EBIT forward of Ocugen Inc – SWB:2H51 - TradingView
Price to earnings forward of Ocugen Inc – SWB:2H51 - TradingView
OCGN Forecast — Price Target — Prediction for 2027 - TradingView
Ocugen: Financing Risk Is Lower, But The Clinical Bet Still Has To Work - Seeking Alpha
Ocugen (OCGN) Stock Draws Fresh Price Target Split After Cautious Analyst View - Yahoo Finance
Ocugen Inc (OCGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ocugen Inc. stock rises Tuesday, outperforms market - MarketWatch
OCGN Stock Holds Buy Rating As Analyst Trims Price Target - StocksToTrade
Ocugen completes OCU400 Phase 3 enrollment, shares trade in tight NASDAQ range - Ad-hoc-news.de
Ocugen Inc Azioni (OCGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ocugen Inc Azioni (OCGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zhang Junge | Director |
Apr 01 '26 |
Option Exercise |
0.79 |
194,134 |
154,303 |
1,359,316 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):